We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Shareholder prophylacticism

24 February 2020 By John Foley

Aggressive takeover defenses give boards breathing space, but don’t always help investors. Even poster child Airgas doesn’t provide a knockout case. HP’s defense against Xerox is neither the first or the worst. But most poison pills let boards ignore problems until it’s too late.

This content is for Subscribers only

 

Email a friend

Please complete the form below.

Required fields *

*
*
*

(Separate multiple email addresses with commas)